Global Biopharmaceutical Market (By Product Type- Testosterone Gel, Biotech Vaccines, Human Growth Hormones, Purified Proteins and Others. By Therapeutic- Oncology, Newrology, Cardiovascular, Diabetes, and Other Therapy Treatment. By End-User- Healthcare Center, Pharmaceutical Sector and Research Institutes) – Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2017 – 2025
The report covers the analysis and forecast of a biopharmaceutical market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Mn).
The study provides a detailed view of the biopharmaceutical market, by segmenting it based on by type of product, by therapeutic, by end-user, and regional demand. Increasing adoption of biopharmaceutical product, therapeutic in healthcare sector, pharmaceutical sector and in few more sector is one of the key factor fueling the growth of the market. Biopharmaceuticals are medicines which are produced from organic sources and has a less drawback in their products and services. Therefore, the global demand for a biopharmaceutical drugs market is increasing. High demand of therapecutic treatment and organic products and services among the ageing consumer. Moreover, increasing number of diseases, creates a huge market opportunity for biopharmaceutical market during the forecasted years.
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by type of product, by therapeutic, and by end-users in all regions. These include different business strategies adopted by the leading players and their recent developments.
A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the biopharmaceutical market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the Biopharmaceuticals market.
The report provides the size of the Biopharmaceuticals market in 2017 and the forecast for the next nine years up to 2025. The size of the global Biopharmaceuticals market is provided in terms of revenue. Market revenue is defined in US$ Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.
Market estimates for this study have been based on revenue being derived through regional pricing trends. The biopharmaceutical market has been analyzed based on expected demand. We have used the bottom-up approach to estimate the global revenue of the biopharmaceutical market, split into regions. Based on, product type, therapeutic, and by end-user we have summed up the individual revenues from all the regions to achieve the global revenue for biopharmaceutical market. Companies were considered for the market share analysis, based on their innovation and application and revenue generation. In the absence of specific data related to the sales of biopharmaceutical product several privately held companies, calculated assumptions have been made in view of the company’s penetration and regional presence.
The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include LG Life Science, Pfizer, Johnson& Johnson, Ranbaxy Laboratories, Biocon, GlaxSmithKline, Roche Holing AG, and few to be named.
The global biopharmaceutical market has been segmented into:
Global Biopharmaceuticals Market: By Product Type
The study provides a detailed view of the biopharmaceutical market, by segmenting it based on by type of product, by therapeutic, by end-user, and regional demand. Increasing adoption of biopharmaceutical product, therapeutic in healthcare sector, pharmaceutical sector and in few more sector is one of the key factor fueling the growth of the market. Biopharmaceuticals are medicines which are produced from organic sources and has a less drawback in their products and services. Therefore, the global demand for a biopharmaceutical drugs market is increasing. High demand of therapecutic treatment and organic products and services among the ageing consumer. Moreover, increasing number of diseases, creates a huge market opportunity for biopharmaceutical market during the forecasted years.
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by type of product, by therapeutic, and by end-users in all regions. These include different business strategies adopted by the leading players and their recent developments.
A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the biopharmaceutical market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the Biopharmaceuticals market.
The report provides the size of the Biopharmaceuticals market in 2017 and the forecast for the next nine years up to 2025. The size of the global Biopharmaceuticals market is provided in terms of revenue. Market revenue is defined in US$ Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.
Market estimates for this study have been based on revenue being derived through regional pricing trends. The biopharmaceutical market has been analyzed based on expected demand. We have used the bottom-up approach to estimate the global revenue of the biopharmaceutical market, split into regions. Based on, product type, therapeutic, and by end-user we have summed up the individual revenues from all the regions to achieve the global revenue for biopharmaceutical market. Companies were considered for the market share analysis, based on their innovation and application and revenue generation. In the absence of specific data related to the sales of biopharmaceutical product several privately held companies, calculated assumptions have been made in view of the company’s penetration and regional presence.
The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include LG Life Science, Pfizer, Johnson& Johnson, Ranbaxy Laboratories, Biocon, GlaxSmithKline, Roche Holing AG, and few to be named.
The global biopharmaceutical market has been segmented into:
Global Biopharmaceuticals Market: By Product Type
- Testosterone Gel
- Biotech vaccines
- Human growth hormones
- Purified proteins
- Others
- Oncology
- Newrology
- Cardiovascular
- Diabetes
- Other related treatment
- Healthcare center
- Pharmaceutical sector
- Research institutes
- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- France
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- India
- China
- Japan
- Rest of Asia Pacific
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
- Latin America
- Brazil
- Rest of Latin America
1 INTRODUCTION
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 TOP-DOWN APPROACH
2.2 BOTTOM-UP APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL BIOPHARMACEUTICAL MARKET SNAPSHOT
3.2 GLOBAL BIOPHARMACEUTICAL MARKET REVENUE, 2017– 2025(US$ MN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL BIOPHARMACEUTICAL , BY PRODUCT TYPE
5.1 OVERVIEW
5.2 TESTOSTERONE GEL
5.3 BIOTECH VACCINES
5.4 HUMAN GROWTH HORMONES
5.5 PURIFIED PROTEINS
5.6 OTHERS
6 GLOBAL BIOPHARMACEUTICAL , BY THERAPEUTIC AREAS
6.1 OVERVIEW
6.2 ONCOLOGY
6.3 NEWROLOGY
6.4 CARDIOVASCULAR
6.5 DIABETES
6.6 OTHERS THERAPEUTIC AREA
7 GLOBAL BIOPHARMACEUTICAL MARKET, BY END-USER
7.1 RESEARCH CENTER
7.2 PHARMACEUTICAL SECTOR
7.3 HEALTH CARE INDUSTRY
8 GLOBAL BIOPHARMACEUTICAL MARKET, BY GEOGRAPHY
8.1 NORTH AMERICA
8.1.1 MARKET DYNAMICS
8.1.1.1 DRIVERS
8.1.1.2 RESTRAINTS
8.1.1.3 OPPORTUNITY
8.1.2 U.S.
8.1.3 CANADA
8.1.4 MEXICO
8.2 EUROPE
8.2.1 MARKET DYNAMICS
8.2.1.1 DRIVERS
8.2.1.2 RESTRAINTS
8.2.1.3 OPPORTUNITY
8.2.2 U.K.
8.2.3 FRANCE
8.2.4 GERMANY
8.2.5 SPAIN
8.2.6 REST OF EUROPE
8.3 ASIA PACIFIC
8.3.1 MARKET DYNAMICS
8.3.1.1 DRIVERS
8.3.1.2 RESTRAINTS
8.3.1.3 OPPORTUNITY
8.3.2 INDIA
8.3.3 CHINA
8.3.4 JAPAN
8.3.5 REST OF ASIA PACIFIC
8.4 MIDDLE EAST AND AFRICA
8.4.1 MARKET DYNAMICS
8.4.1.1 DRIVERS
8.4.1.2 RESTRAINTS
8.4.1.3 OPPORTUNITY
8.4.2 SOUTH AFRICA
8.4.3 REST OF MIDDLE EAST AND AFRICA
8.5 LATIN AMERICA
8.5.1 MARKET DYNAMICS
8.5.1.1 DRIVERS
8.5.1.2 RESTRAINTS
8.5.1.3 OPPORTUNITY
8.5.2 BRAZIL
8.5.3 REST OF LATIN AMERICA
9 GLOBAL BIOPHARMACEUTICAL MARKET, BY COMPANY
9.1 INTRODUCTION
9.2 LG LIFE SCIENCE
9.2.1 BUSINESS OVERVIEW
9.2.2 PRODUCTS & SERVICES
9.2.3 KEY STRATEGY
9.2.4 RECENT DEVELOPMENTS
9.2.5 SWOT ANALYSIS
9.3 PFIZER
9.3.1 BUSINESS OVERVIEW
9.3.2 PRODUCTS & SERVICES
9.3.3 KEY STRATEGY
9.3.4 RECENT DEVELOPMENTS
9.3.5 SWOT ANALYSIS
9.4 JOHNSON& JOHNSON
9.4.1 BUSINESS OVERVIEW
9.4.2 PRODUCTS & SERVICES
9.4.3 KEY STRATEGY
9.4.4 RECENT DEVELOPMENTS
9.4.5 SWOT ANALYSIS
9.5 ROCHE HOLDING AG
9.5.1 BUSINESS OVERVIEW
9.5.2 PRODUCTS & SERVICES
9.5.3 KEY STRATEGY
9.5.4 RECENT DEVELOPMENTS
9.5.5 SWOT ANALYSIS
9.6 BIOCON LTD
9.6.1 BUSINESS OVERVIEW
9.6.2 PRODUCTS & SERVICES
9.6.3 KEY STRATEGY
9.6.4 RECENT DEVELOPMENTS
9.6.5 SWOT ANALYSIS
9.7 RANBAXY LABORATORIES LTD
9.7.1 BUSINESS OVERVIEW
9.7.2 PRODUCTS & SERVICES
9.7.3 KEY STRATEGY
9.7.4 RECENT DEVELOPMENTS
9.7.5 SWOT ANALYSIS
9.8 GLAXOSMITHKLINE
9.8.1 BUSINESS OVERVIEW
9.8.2 PRODUCTS & SERVICES
9.8.3 KEY STRATEGY
9.8.4 RECENT DEVELOPMENTS
9.8.5 SWOT ANALYSIS
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 TOP-DOWN APPROACH
2.2 BOTTOM-UP APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL BIOPHARMACEUTICAL MARKET SNAPSHOT
3.2 GLOBAL BIOPHARMACEUTICAL MARKET REVENUE, 2017– 2025(US$ MN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL BIOPHARMACEUTICAL , BY PRODUCT TYPE
5.1 OVERVIEW
5.2 TESTOSTERONE GEL
5.3 BIOTECH VACCINES
5.4 HUMAN GROWTH HORMONES
5.5 PURIFIED PROTEINS
5.6 OTHERS
6 GLOBAL BIOPHARMACEUTICAL , BY THERAPEUTIC AREAS
6.1 OVERVIEW
6.2 ONCOLOGY
6.3 NEWROLOGY
6.4 CARDIOVASCULAR
6.5 DIABETES
6.6 OTHERS THERAPEUTIC AREA
7 GLOBAL BIOPHARMACEUTICAL MARKET, BY END-USER
7.1 RESEARCH CENTER
7.2 PHARMACEUTICAL SECTOR
7.3 HEALTH CARE INDUSTRY
8 GLOBAL BIOPHARMACEUTICAL MARKET, BY GEOGRAPHY
8.1 NORTH AMERICA
8.1.1 MARKET DYNAMICS
8.1.1.1 DRIVERS
8.1.1.2 RESTRAINTS
8.1.1.3 OPPORTUNITY
8.1.2 U.S.
8.1.3 CANADA
8.1.4 MEXICO
8.2 EUROPE
8.2.1 MARKET DYNAMICS
8.2.1.1 DRIVERS
8.2.1.2 RESTRAINTS
8.2.1.3 OPPORTUNITY
8.2.2 U.K.
8.2.3 FRANCE
8.2.4 GERMANY
8.2.5 SPAIN
8.2.6 REST OF EUROPE
8.3 ASIA PACIFIC
8.3.1 MARKET DYNAMICS
8.3.1.1 DRIVERS
8.3.1.2 RESTRAINTS
8.3.1.3 OPPORTUNITY
8.3.2 INDIA
8.3.3 CHINA
8.3.4 JAPAN
8.3.5 REST OF ASIA PACIFIC
8.4 MIDDLE EAST AND AFRICA
8.4.1 MARKET DYNAMICS
8.4.1.1 DRIVERS
8.4.1.2 RESTRAINTS
8.4.1.3 OPPORTUNITY
8.4.2 SOUTH AFRICA
8.4.3 REST OF MIDDLE EAST AND AFRICA
8.5 LATIN AMERICA
8.5.1 MARKET DYNAMICS
8.5.1.1 DRIVERS
8.5.1.2 RESTRAINTS
8.5.1.3 OPPORTUNITY
8.5.2 BRAZIL
8.5.3 REST OF LATIN AMERICA
9 GLOBAL BIOPHARMACEUTICAL MARKET, BY COMPANY
9.1 INTRODUCTION
9.2 LG LIFE SCIENCE
9.2.1 BUSINESS OVERVIEW
9.2.2 PRODUCTS & SERVICES
9.2.3 KEY STRATEGY
9.2.4 RECENT DEVELOPMENTS
9.2.5 SWOT ANALYSIS
9.3 PFIZER
9.3.1 BUSINESS OVERVIEW
9.3.2 PRODUCTS & SERVICES
9.3.3 KEY STRATEGY
9.3.4 RECENT DEVELOPMENTS
9.3.5 SWOT ANALYSIS
9.4 JOHNSON& JOHNSON
9.4.1 BUSINESS OVERVIEW
9.4.2 PRODUCTS & SERVICES
9.4.3 KEY STRATEGY
9.4.4 RECENT DEVELOPMENTS
9.4.5 SWOT ANALYSIS
9.5 ROCHE HOLDING AG
9.5.1 BUSINESS OVERVIEW
9.5.2 PRODUCTS & SERVICES
9.5.3 KEY STRATEGY
9.5.4 RECENT DEVELOPMENTS
9.5.5 SWOT ANALYSIS
9.6 BIOCON LTD
9.6.1 BUSINESS OVERVIEW
9.6.2 PRODUCTS & SERVICES
9.6.3 KEY STRATEGY
9.6.4 RECENT DEVELOPMENTS
9.6.5 SWOT ANALYSIS
9.7 RANBAXY LABORATORIES LTD
9.7.1 BUSINESS OVERVIEW
9.7.2 PRODUCTS & SERVICES
9.7.3 KEY STRATEGY
9.7.4 RECENT DEVELOPMENTS
9.7.5 SWOT ANALYSIS
9.8 GLAXOSMITHKLINE
9.8.1 BUSINESS OVERVIEW
9.8.2 PRODUCTS & SERVICES
9.8.3 KEY STRATEGY
9.8.4 RECENT DEVELOPMENTS
9.8.5 SWOT ANALYSIS
